PROTEST
Ono Pharma Announces Results from Five Phase 2 Clinical Studies of Ono 1110 an Endocannabinoid Modulator
PROTEST signal, reported in JA, from newswiretoday.com, with negative sentiment. Locations: Osaka, Japan.
What This Signal Means
This page turns one GDELT event record into a readable WorldEchoNews signal. The signal is categorized as PROTEST for JA, with negative sentiment and a tone score of -6.20. 1 distinct reporting source linked to this event.
Tone Reading
The tone score is used as a quick language-intensity indicator. Scores below -5 are treated as negative, scores above 5 are treated as positive, and values between -5 and 5 are treated as neutral. This signal has a strong negative reading.
Reporting Sources
These source names were attached to matching GDELT mentions for this event.
newswiretoday.com
People: Toichi Takino
Organizations: Pharmaceuticals Basel, Society Of Interstitial Cystitis Of Japan, Fibromyalgia Clinical Practice Guideline Development Group, Clarivate Plc
Locations: Osaka, Japan
Activity in JA (last 24 hours)
104signals recorded
-1.39average tone
9strongly negative
Counted across every source WorldEchoNews processed in the window, not just this story.